Chloroplast-Derived Therapeutic and Prophylactic Vaccines

Chapter

Abstract

Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually as a result of inadequate prophylactic or therapeutic treatments against infectious diseases (World Health Organization 2008). The emphasis on profitability by the pharmaceutical industry has led to development of high-cost vaccines targeting diseases with high profit margins, resulting in an annual death toll for developing countries that is largely preventable. Daniell and ­co-investigators published the first expression of a vaccine antigen, cholera toxin subunit B, through transgenic tobacco chloroplasts in 2001. The polyploidy nature of the chloroplast genome enables engineering of a high copy number of target gene, while the translational machinery of the plastid directs the synthesis of bioactive proteins with proper folding, disulfide bond formation, and lipidation. Furthermore, gene integration is site-specific, expression is polycistronic, and natural gene containment occurs due to the maternal inheritance of the chloroplast genome. The chloroplast transformation technology (CTT) has been used to express proteins of bacterial, viral, protozoan, and recently mammalian origins that may be subsequently utilized in immunization strategies to produce protective or therapeutic immunity. Such chloroplast-derived vaccines represent an inexpensive and effective means of producing antigen-subunit vaccines. Furthermore, transformation of edible crops such as lettuce could generate stable orally-deliverable vaccine antigens through inexpensive field production and agricultural drying techniques. This platform could therefore obviate cold-chain logistics and the requirement of sterile injectables, drastically reducing downstream production costs of such biopharmaceuticals. With these proof-of-concept studies, focus within CTT is shifting towards establishing a viable platform for human immunization by demonstrating the ­functionality of such chloroplast derived proteins, emphasizing the need to develop edible plant-based alternatives to tobacco, and improving efficacy through ­additional peptide fusion-domains.

Keywords

Chloroplast Genome Total Soluble Protein Oral Delivery Protective Antigen Vaccine Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgement

The contribution here was supported in part by funding from the Arnold and Mabel Beckman Foundation to James S. New, and by grants from USDA-CSREES 2009-39200-19972, USDA-NIFA 2010-39200-21704 and NIH R01 GM 63879–08 to Henry Daniell.

References

  1. Aide P, Bassat Q, Alonso PL (2007) Towards an effective malaria vaccine. Arch Dis Child 92:476–479CrossRefGoogle Scholar
  2. Apel W, Schulze WX, Bock R (2010) Identification of protein stability determinants in chloroplasts. Plant J 63:636–650CrossRefGoogle Scholar
  3. Arlen PA, Falconer R, Cherukumilli S, Cole A, Cole AM, Oishi KK, Daniell H (2007) Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol J 5:511–525CrossRefGoogle Scholar
  4. Arlen PA, Singleton M, Adamovicz JJ, Ding Y, Davoodi-Semiromi A, Daniell H (2008) Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infect Immun 76:3640–3650CrossRefGoogle Scholar
  5. Bally J, Nadai M, Vitel M, Rolland A, Dumain R, Dubald M (2009) Plant physiological adaptations to the massive foreign protein synthesis occurring in recombinant chloroplasts. Plant Physiol 150:1474–1481CrossRefGoogle Scholar
  6. Boyhan D, Daniell H (2011) Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnol J 9:585–598CrossRefGoogle Scholar
  7. Chebolu S, Daniell H (2007) Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnol J 5:230–239CrossRefGoogle Scholar
  8. Cybulski RJ Jr, Sanz P, O’Brien AD (2009) Anthrax vaccination strategies. Mol Aspects Med 30:490–502CrossRefGoogle Scholar
  9. Daniell H (2007) Transgene containment by maternal inheritance: effective or elusive? Proc Natl Acad Sci USA 104:6879–6880CrossRefGoogle Scholar
  10. Daniell H, Lee SB, Panchal T, Wiebe PO (2001) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 311:1001–1009CrossRefGoogle Scholar
  11. Daniell H, Ruiz G, Denes B, Sandberg L, Langridge W (2009a) Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function. BMC Biotechnol 9:33CrossRefGoogle Scholar
  12. Daniell H, Singh ND, Mason H, Streatfield SJ (2009b) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14:669–679CrossRefGoogle Scholar
  13. Davoodi-Semiromi A, Schreiber M, Nalapalli S, Verma D, Singh ND, Banks RK, Chakrabarti D, Daniell H (2010) Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol J 8:223–242CrossRefGoogle Scholar
  14. DiMichele DM (2006) Inhibitor treatment in haemophilias A and B: inhibitor diagnosis. Haemophilia 12(Suppl 6):37–41, discussion 41–32CrossRefGoogle Scholar
  15. Dreesen IA, Charpin-El Hamri G, Fussenegger M (2010) Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection. J Biotechnol 145:273–280CrossRefGoogle Scholar
  16. Eibl C, Zou Z, Beck A, Kim M, Mullet J, Koop HU (1999) In vivo analysis of plastid psbA, rbcL and rpl32 UTR elements by chloroplast transformation: tobacco plastid gene expression is controlled by modulation of transcript levels and translation efficiency. Plant J 19:333–345CrossRefGoogle Scholar
  17. Fernandez-San Millan A, Ortigosa SM, Hervas-Stubbs S, Corral-Martinez P, Segui-Simarro JM, Gaetan J, Coursaget P, Veramendi J (2008) Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J 6:427–441CrossRefGoogle Scholar
  18. Forman S, Le Gall F, Belton D, Evans B, Francois JL, Murray G, Sheesley D, Vandersmissen A, Yoshimura S (2009) Moving towards the global control of foot and mouth disease: an opportunity for donors. Rev Sci Tech 28:883–896Google Scholar
  19. Geyer M, Peterlin BM (2001) Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett 496:91–95CrossRefGoogle Scholar
  20. Glenz K, Bouchon B, Stehle T, Wallich R, Simon MM, Warzecha H (2006) Production of a recombinant bacterial lipoprotein in higher plant chloroplasts. Nat Biotechnol 24:76–77CrossRefGoogle Scholar
  21. Gonzalez-Rabade N, McGowan EG, Zhou F, McCabe MS, Bock R, Dix PJ, Gray JC, Ma JK (2011) Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice. Plant Biotechnol J. doi:10.1111/ j.1467-7652.2011.00609.xGoogle Scholar
  22. Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R (2011) A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax. Vaccine. doi: 10.1016/j.vaccine.2011.03.082
  23. Goronzy JJ, Weyand CM (2007) The innate and adaptive immune systems. In: Goldman L, Ausiello D (eds) Cecil medicine, 23rd edn. Saunders Elsevier, Philadelphia, chap 42Google Scholar
  24. Greenwood BM, Bojang K, Whitty CJ, Targett GA (2005) Malaria. Lancet 365:1487–1498CrossRefGoogle Scholar
  25. He DM, Qian KX, Shen GF, Zhang ZF, Li YN, Su ZL, Shao HB (2007) Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chroloplasts. Colloids Surf B Biointerfaces 55:26–30CrossRefGoogle Scholar
  26. Herman RA, Korjagin VA, Schafer BW (2005) Quantitative measurement of protein digestion in simulated gastric fluid. Regul Toxicol Pharmacol 41:175–184CrossRefGoogle Scholar
  27. Herman RA, Storer NP, Gao Y (2006) Digestion assays in allergenicity assessment of transgenic proteins. Environ Health Perspect 114:1154–1157CrossRefGoogle Scholar
  28. Hills CE, Brunskill NJ (2009) Cellular and physiological effects of C-peptide. Clin Sci (Lond) 116:565–574CrossRefGoogle Scholar
  29. Kanagaraj AP, Verma D, Daniell H (2011) Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts. Plant Mol Biol 76:323–333CrossRefGoogle Scholar
  30. Kang TJ, Loc NH, Jang MO, Jang YS, Kim YS, Seo JE, Yang MS (2003) Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Transgenic Res 12:683–691CrossRefGoogle Scholar
  31. Kang TJ, Han SC, Kim MY, Kim YS, Yang MS (2004) Expression of non-toxic mutant of Escherichia coli heat-labile enterotoxin in tobacco chloroplasts. Protein Expr Purif 38:123–128CrossRefGoogle Scholar
  32. Kirk DD, Webb SR (2005) The next 15 years: taking plant-made vaccines beyond proof of concept. Immunol Cell Biol 83:248–256CrossRefGoogle Scholar
  33. Koya V, Moayeri M, Leppla SH, Daniell H (2005) Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect Immun 73:8266–8274CrossRefGoogle Scholar
  34. Langeveld JP, Casal JI, Osterhaus AD, Cortes E, de Swart R, Vela C, Dalsgaard K, Puijk WC, Schaaper WM, Meloen RH (1994) First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol 68:4506–4513Google Scholar
  35. Lee MY, Zhou Y, Lung RW, Chye ML, Yip WK, Zee SY, Lam E (2006) Expression of viral capsid protein antigen against Epstein-Barr virus in plastids of Nicotiana tabacum cv. SR1. Biotechnol Bioeng 94:1129–1137CrossRefGoogle Scholar
  36. Lee SB, Li B, Jin S, Daniell H (2010) Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol J 9:100–115CrossRefGoogle Scholar
  37. Lentz EM, Segretin ME, Morgenfeld MM, Wirth SA, Dus Santos MJ, Mozgovoj MV, Wigdorovitz A, Bravo-Almonacid FF (2009) High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants. Planta 231:387–395CrossRefGoogle Scholar
  38. Limaye A, Koya V, Samsam M, Daniell H (2006) Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J 20:959–961CrossRefGoogle Scholar
  39. Loemba H, Brenner B, Parniak MA, Ma’ayan S, Spira B, Moisi D, Oliveira M, Detorio M, Wainberg MA (2002) Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Antimicrob Agents Chemother 46:2087–2094CrossRefGoogle Scholar
  40. Lossl AG, Waheed MT (2011) Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. Plant Biotechnol J 9:527–539CrossRefGoogle Scholar
  41. Lotter H, Khajawa F, Stanley SL Jr, Tannich E (2000) Protection of gerbils from amebic liver abscess by vaccination with a 25-mer peptide derived from the cysteine-rich region of Entamoeba histolytica galactose-specific adherence lectin. Infect Immun 68:4416–4421CrossRefGoogle Scholar
  42. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520–532CrossRefGoogle Scholar
  43. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265–1273Google Scholar
  44. Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805CrossRefGoogle Scholar
  45. Madesis P, Osathanunkul M, Georgopoulou U, Gisby MF, Mudd EA, Nianiou I, Tsitoura P, Mavromara P, Tsaftaris A, Day A (2009) A hepatitis C virus core polypeptide expressed in chloroplasts detects anti-core antibodies in infected human sera. J Biotechnol 145:377–386CrossRefGoogle Scholar
  46. Maher B (2008) Malaria: the end of the beginning. Nature 451:1042–1046CrossRefGoogle Scholar
  47. Matsui K, Gromowski GD, Li L, Barrett AD (2010) Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. J Gen Virol 91:2249–2253CrossRefGoogle Scholar
  48. Molina A, Hervas-Stubbs S, Daniell H, Mingo-Castel AM, Veramendi J (2004) High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol J 2:141–153CrossRefGoogle Scholar
  49. Molina A, Veramendi J, Hervas-Stubbs S (2005) Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology 342:266–275CrossRefGoogle Scholar
  50. Morgenfeld M, Segretin ME, Wirth S, Lentz E, Zelada A, Mentaberry A, Gissmann L, Bravo-Almonacid F (2009) Potato virus X coat protein fusion to human papillomavirus 16 E7 oncoprotein enhance antigen stability and accumulation in tobacco chloroplast. Mol Biotechnol 43:243–249CrossRefGoogle Scholar
  51. Nagata M, Santamaria P, Kawamura T, Utsugi T, Yoon JW (1994) Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol 152:2042–2050Google Scholar
  52. Oey M, Lohse M, Kreikemeyer B, Bock R (2009a) Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J 57:436–445CrossRefGoogle Scholar
  53. Oey M, Lohse M, Scharff LB, Kreikemeyer B, Bock R (2009b) Plastid production of protein ­antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc Natl Acad Sci USA 106:6579–6584CrossRefGoogle Scholar
  54. Ortigosa SM, Fernandez-San Millan A, Veramendi J (2009) Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain. Transgenic Res 19:703–709CrossRefGoogle Scholar
  55. Passalacqua KD, Bergman NH (2006) Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. Future Microbiol 1:397–415CrossRefGoogle Scholar
  56. Patti JM, Hook M (1994) Microbial adhesins recognizing extracellular matrix macromolecules. Curr Opin Cell Biol 6:752–758CrossRefGoogle Scholar
  57. Pohle T, Domschke W (2003) Gastric function measurements in drug development. Br J Clin Pharmacol 56:156–164CrossRefGoogle Scholar
  58. Que YA, Moreillon P (2004) Infective endocarditis. Nat Rev Cardiol 8:322–336CrossRefGoogle Scholar
  59. Rasala BA, Muto M, Lee PA, Jager M, Cardoso RM, Behnke CA, Kirk P, Hokanson CA, Crea R, Mendez M, Mayfield SP (2010) Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii. Plant Biotechnol J 8:719–733CrossRefGoogle Scholar
  60. Rigano MM, Manna C, Giulini A, Pedrazzini E, Capobianchi M, Castilletti C, Di Caro A, Ippolito G, Beggio P, De Giuli MC, Monti L, Vitale A, Cardi T (2009) Transgenic chloroplasts are efficient sites for high-yield production of the vaccinia virus envelope protein A27L in plant cellsdagger. Plant Biotechnol J 7:577–591CrossRefGoogle Scholar
  61. Rosales-Mendoza S, Alpuche-Solis AG, Soria-Guerra RE, Moreno-Fierros L, Martinez-Gonzalez L, Herrera-Diaz A, Korban SS (2009) Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. Plant J 57:45–54CrossRefGoogle Scholar
  62. Ruhlman T, Ahangari R, Devine A, Samsam M, Daniell H (2007) Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts–oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J 5:495–510CrossRefGoogle Scholar
  63. Ruhlman T, Verma D, Samson N, Daniell H (2010) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol 152:2088–2104CrossRefGoogle Scholar
  64. Rweyemamu MM, Astudillo VM (2002) Global perspective for foot and mouth disease control. Rev Sci Tech 21:765–773Google Scholar
  65. Scotti N, Alagna F, Ferraiolo E, Formisano G, Sannino L, Buonaguro L, De Stradis A, Vitale A, Monti L, Grillo S, Buonaguro FM, Cardi T (2009) High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts. Planta 229:1109–1122CrossRefGoogle Scholar
  66. Sim J-S, Pak H-K, Kim D-S, Lee S-B, Kim Y-H, Hahn B-S (2009) Expression and characterization of synthetic heat-labile enterotoxin B subunit and hemagglutinin–neuraminidase-neutralizing epitope fusion protein in Escherichia coli and tobacco chloroplasts. Plant Mol Biol Rep 27:388–399CrossRefGoogle Scholar
  67. Soria-Guerra RE, Alpuche-Solis AG, Rosales-Mendoza S, Moreno-Fierros L, Bendik EM, Martinez-Gonzalez L, Korban SS (2009) Expression of a multi-epitope DPT fusion protein in transplastomic tobacco plants retains both antigenicity and immunogenicity of all three ­components of the functional oligomer. Planta 229:1293–1302CrossRefGoogle Scholar
  68. Staub JM, Garcia B, Graves J, Hajdukiewicz PT, Hunter P, Nehra N, Paradkar V, Schlittler M, Carroll JA, Spatola L, Ward D, Ye G, Russell DA (2000) High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat Biotechnol 18:333–338CrossRefGoogle Scholar
  69. Streatfield SJ (2005) Mucosal immunization using recombinant plant-based oral vaccines. Methods Mucosal Immun 38:150–157Google Scholar
  70. Thoren KL, Krantz BA (2011) The unfolding story of anthrax toxin translocation. Mol Microbiol 80:588–595CrossRefGoogle Scholar
  71. Tran M, Zhou B, Pettersson PL, Gonzalez MJ, Mayfield SP (2009) Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts. Biotechnol Bioeng 104:663–673Google Scholar
  72. Tregoning JS, Nixon P, Kuroda H, Svab Z, Clare S, Bowe F, Fairweather N, Ytterberg J, van Wijk KJ, Dougan G, Maliga P (2003) Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res 31:1174–1179CrossRefGoogle Scholar
  73. Tregoning JS, Clare S, Bowe F, Edwards L, Fairweather N, Qazi O, Nixon PJ, Maliga P, Dougan G, Hussell T (2005) Protection against tetanus toxin using a plant-based vaccine. Eur J Immunol 35:1320–1326CrossRefGoogle Scholar
  74. Verhounig A, Karcher D, Bock R (2010) Inducible gene expression from the plastid genome by a synthetic riboswitch. Proc Natl Acad Sci USA 107:6204–6209CrossRefGoogle Scholar
  75. Verma D, Daniell H (2007) Chloroplast vector systems for biotechnology applications. Plant Physiol 145:1129–1143CrossRefGoogle Scholar
  76. Verma D, Kanagaraj A, Jin S, Singh ND, Kolattukudy PE, Daniell H (2010a) Chloroplast-derived enzyme cocktails hydrolyse lignocellulosic biomass and release fermentable sugars. Plant Biotechnol J 8:332–350CrossRefGoogle Scholar
  77. Verma D, Moghimi B, LoDuca PA, Singh HD, Hoffman BE, Herzog RW, Daniell H (2010b) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal ­anaphylaxis in hemophilia B mice. Proc Natl Acad Sci USA 107:7101–7106CrossRefGoogle Scholar
  78. Vines RR, Ramakrishnan G, Rogers JB, Lockhart LA, Mann BJ, Petri WA Jr (1998) Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains a beta2 integrin motif. Mol Biol Cell 9:2069–2079Google Scholar
  79. Waheed MT, Thones N, Muller M, Hassan SW, Razavi NM, Lossl E, Kaul HP, Lossl AG (2010) Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. Transgenic Res 20:271–282CrossRefGoogle Scholar
  80. Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320:760–764CrossRefGoogle Scholar
  81. Wang X, Brandsma M, Tremblay R, Maxwell D, Jevnikar AM, Huner N, Ma S (2008) A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). BMC Biotechnol 8:87CrossRefGoogle Scholar
  82. Watson J, Koya V, Leppla SH, Daniell H (2004) Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine 22:4374–4384CrossRefGoogle Scholar
  83. Weiner HL, da Cunha AP, Quintana F, Wu H (2011) Oral tolerance. Immunol Rev 241:241–259CrossRefGoogle Scholar
  84. Worlds Health Organization (2008) Global Burden of Diseae (GBD). The global burden of diseases 2004 update. World Health Organization, Geneva. Available from http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html
  85. Young KR, McBurney SP, Karkhanis LU, Ross TM (2006) Virus-like particles: designing an effective AIDS vaccine. Methods 40:98–117CrossRefGoogle Scholar
  86. Zhou YX, Lee MY, Ng JM, Chye ML, Yip WK, Zee SY, Lam E (2006) A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J Gastroenterol 12:306–312Google Scholar
  87. Zhou F, Badillo-Corona JA, Karcher D, Gonzalez-Rabade N, Piepenburg K, Borchers AM, Maloney AP, Kavanagh TA, Gray JC, Bock R (2008) High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes. Plant Biotechnol J 6:897–913CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • James S. New
    • 1
  • Donevan Westerveld
    • 1
  • Henry Daniell
    • 1
  1. 1.Department of Molecular Biology and Microbiology, College of MedicineUniversity of Central FloridaOrlandoUSA

Personalised recommendations